Fundies.
English

WEIKANG BIO-TECH

EDGAR
Quarterly report (10-Q) · filed 2009-11-19

12 filing records in this dataset, filed from 2007-04-02 to 2009-11-19. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

11.2 million USD

2009-09-30 · USD

Exact inputs and evidence

Operating margin

45.83%

2009-09-30 · %

Exact inputs and evidence
  • Operating Income: 5145964 USD Source
  • Revenue: 11227275 USD Source

Operating cash flow

3.72 million USD

2009-09-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: 11325254 USD Source
  • Operating Cash Flow: 7603863 USD Source

Free cash flow

3.7 million USD

2009-09-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: 11325254 USD Source
  • Operating Cash Flow: 7603863 USD Source
  • Capital Expenditure: 27751 USD Source
  • Capital Expenditure: 2187 USD Source
Cash and cash equivalents
8.71 million USD Source
Exact value

8708443 USD

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

40.7 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence
  • Revenue: 12852884 USD · 2008-01-01 – 2008-12-31 Source
  • Revenue: 6651947 USD · 2008-01-01 – 2008-09-30 Source
  • Revenue: 10111207 USD · 2009-01-01 – 2009-03-31 Source
  • Revenue: 13195767 USD · 2009-04-01 – 2009-06-30 Source
  • Revenue: 11227275 USD · 2009-07-01 – 2009-09-30 Source

Net income

14.9 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence
  • Net income: 7270609 USD · 2008-01-01 – 2008-12-31 Source
  • Net income: 3492395 USD · 2008-01-01 – 2008-09-30 Source
  • Net income: 3853605 USD · 2009-01-01 – 2009-03-31 Source
  • Net income: 3334325 USD · 2009-04-01 – 2009-06-30 Source
  • Net income: 3978231 USD · 2009-07-01 – 2009-09-30 Source

Operating cash flow

17.8 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence
  • Operating cash flow: 10178609 USD · 2008-01-01 – 2008-12-31 Source
  • Operating cash flow: 3698792 USD · 2008-01-01 – 2008-09-30 Source
  • Operating cash flow: 4518083 USD · 2009-01-01 – 2009-03-31 Source
  • Operating cash flow: 7603863 USD · 2009-01-01 – 2009-06-30 Source
  • Operating cash flow: 4518083 USD · 2009-01-01 – 2009-03-31 Source
  • Operating cash flow: 11325254 USD · 2009-01-01 – 2009-09-30 Source
  • Operating cash flow: 7603863 USD · 2009-01-01 – 2009-06-30 Source

Capital expenditure

802 thousand USD

2008-10-01 – 2009-09-30

Exact inputs and evidence
  • Capital expenditure: 808739 USD · 2008-01-01 – 2008-12-31 Source
  • Capital expenditure: 34616 USD · 2008-01-01 – 2008-09-30 Source
  • Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
  • Capital expenditure: 2187 USD · 2009-01-01 – 2009-06-30 Source
  • Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
  • Capital expenditure: 27751 USD · 2009-01-01 – 2009-09-30 Source
  • Capital expenditure: 2187 USD · 2009-01-01 – 2009-06-30 Source

Free cash flow

17 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence
  • Operating cash flow: 10178609 USD · 2008-01-01 – 2008-12-31 Source
  • Operating cash flow: 3698792 USD · 2008-01-01 – 2008-09-30 Source
  • Operating cash flow: 4518083 USD · 2009-01-01 – 2009-03-31 Source
  • Operating cash flow: 7603863 USD · 2009-01-01 – 2009-06-30 Source
  • Operating cash flow: 4518083 USD · 2009-01-01 – 2009-03-31 Source
  • Operating cash flow: 11325254 USD · 2009-01-01 – 2009-09-30 Source
  • Operating cash flow: 7603863 USD · 2009-01-01 – 2009-06-30 Source
  • Capital expenditure: 808739 USD · 2008-01-01 – 2008-12-31 Source
  • Capital expenditure: 34616 USD · 2008-01-01 – 2008-09-30 Source
  • Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
  • Capital expenditure: 2187 USD · 2009-01-01 – 2009-06-30 Source
  • Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
  • Capital expenditure: 27751 USD · 2009-01-01 – 2009-09-30 Source
  • Capital expenditure: 2187 USD · 2009-01-01 – 2009-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-11-19.

Financial data available through: 2008-12-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2008-12-31
  • Operating income: 1 of 11 periods available· newest 2008-12-31
  • Net income: 1 of 11 periods available· newest 2008-12-31
  • Operating cash flow: 1 of 11 periods available· newest 2008-12-31
  • Capital expenditure: 1 of 11 periods available· newest 2008-12-31
  • Total assets: 1 of 11 periods available· newest 2008-12-31
  • liabilities: No compatible figures in this window
  • Current assets: 1 of 11 periods available· newest 2008-12-31
  • Current liabilities: 1 of 11 periods available· newest 2008-12-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2008-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

  • Revenue USD 12.85 million 100% of revenue
  • Cost of revenue USD 4.58 million 36% of revenue
  • Operating expenses USD 1.21 million 9.4% of revenue
  • Operating income USD 7.06 million 55% of revenue
  • Tax, interest and other Derived −USD 210,816 −1.6% of revenue
  • Net income USD 7.27 million 57% of revenue

Cash

  • Operating cash flow USD 10.18 million 79% of revenue
  • Capital expenditure USD 808,739 6.3% of revenue
  • Free cash flow Derived USD 9.37 million 73% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2008 Net income was higher than operating income, so the split is not drawn.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2008 2008-01-01 – 2008-12-3112852884 5793091 Derived 7059793 -210816 Derived 7270609 9369870 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 12.9M 2008
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.9M10.4M6.9M3.5M0.02008
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2008Revenue12852884

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2008Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 54.9% 2008
Net margin 56.6% 2008
Free cash flow margin 72.9% 2008
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.79%59%39%20%0%2008
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2008Operating margin54.9%
2008Net margin56.6%
2008Free cash flow margin72.9%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 10.2M 2008
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.0M8.2M5.5M2.7M0.02008
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2008Operating cash flow10178609

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 9.4M 2008
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.1M7.6M5.1M2.5M0.02008
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2008Free cash flow9369870

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2008-12-31Liabilities / assetsNot reported

Current assets to current liabilities

Current assets divided by current liabilities.

0.11× 2008
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.12×0.09×0.06×0.03×0.00×2008
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2008Current assets / current liabilities0.11×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2008 2008-01-01 – 2008-12-31
USD 7.27 million
Exact value

Exact value: 7270609 USD

2008-01-01 – 2008-12-31: 7270609 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 10.18 million
Exact value

Exact value: 10178609 USD

2008-01-01 – 2008-12-31: 10178609 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 808,739
Exact value

Exact value: 808739 USD

2008-01-01 – 2008-12-31: 808739 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 9.37 million
Calculation and evidence

10178609 − 808739 USD

Exact free cash flow: 9369870 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 0 latest values · 0 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001365354, 1365354, edgar:1365354

Also known as Expedition Leasing,Inc., WEIKANG BIO-TECHNOLOGY GROUP CO INC